Latest Breaking News On - Pacira biosciences company profile - Page 1 : comparemela.com

Premier Fund Managers Ltd Sells 3,310 Shares of Pacira BioSciences, Inc (NASDAQ:PCRX)

Premier Fund Managers Ltd cut its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 124,533 shares of the company’s stock after selling 3,310 shares during the period. Premier Fund […]

United statesPacira biosciencesCampbell co investment adviserExchange commissionGlobal alpha capital management ltdCape investment advisory incPacira biosciences incSecurities exchange commissionRoyal bankQuest partnersPacira biosciences company profileFund managers ltdHillsdale investment management incPremier fund managers ltdFree reportInvestment advisory

Needham & Company LLC Trims Pacira BioSciences (NASDAQ:PCRX) Target Price to $43 00

Needham & Company LLC Trims Pacira BioSciences (NASDAQ:PCRX) Target Price to $43 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesNeedham companyJpmorgan chase coRoyal bankSecurities exchange commissionGroup wealth managementCape investment advisory incPacira biosciences company profilePacira biosciences incChina universal asset management coQuadrant capital groupNisa investment advisorsGet free reportDirector garyExchange commission

Pacira BioSciences (NASDAQ:PCRX) Rating Reiterated by HC Wainwright

Pacira BioSciences (NASDAQ:PCRX) Rating Reiterated by HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesIllinois municipal retirement fundRoyal bankChina universal asset management coJpmorgan chase coPacira biosciences company profileMitsubishi ufjPacira biosciences incTexas permanent school fund corpKokusai asset management coNeedham companyJp morgan private wealth advisorsGet free reportDirector garyAsset management

Analysts Set Pacira BioSciences, Inc (NASDAQ:PCRX) PT at $49 50

Analysts Set Pacira BioSciences, Inc (NASDAQ:PCRX) PT at $49 50
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesMitsubishi ufjNeedham companyChina universal asset management coKokusai asset management coJp morgan private wealth advisorsPacira biosciences company profilePacira biosciences incIllinois municipal retirement fundRoyal bankGet free reportDirector garyAsset managementUniversal asset managementPrivate wealth advisors

Pacira BioSciences, Inc (NASDAQ:PCRX) Given Average Rating of Buy by Brokerages

Pacira BioSciences, Inc (NASDAQ:PCRX) Given Average Rating of Buy by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPacira biosciencesMitsubishi ufjNeedham companyChina universal asset management coKokusai asset management coJp morgan private wealth advisorsPacira biosciences company profileJpmorgan chase coPacira biosciences incSecurities exchange commissionIllinois municipal retirement fundRoyal bankGet free reportMarketbeat ratingsBiosciences trading down